TABLE 2.

Serological, virological, and immunological characteristics of the 35 women preincluded in the ANRS 1201/1202 Ditrame Plus program and diagnosed on-site with dual HIV-1 and HIV-2 infections by the Genie II assay

Patient no.	Serological results by:a				HIV-1 and HIV-2 proviral DNA detected by real-time PCRsa	CD4+-T-cells
	Genie II assay	Peptilav assay	WB assays for HIV-1 and -2	Homemade EIAs (gp41/36 and V3)		%	No. of cells/mm3
10	1 + 2	1 + 2	1 + 2	1 + 2	1 + 2	32	466
11	1 + 2	1 + 2	1 + 2	1 + 2	1 + 2	24.3	561
16	1 + 2	1 + 2	1 + 2	1 + 2	1 + 2	7	169
19	1 + 2	1 + 2	1 + 2	1 + 2	1 + 2	16.8	379
26	1 + 2	1 + 2	1 + 2	1 + 2	1 + 2	36.4	530
33	1 + 2	1 + 2	1 + 2	1 + 2	1 + 2	25.6	506
34	1 + 2	1 + 2	1 + 2	1 + 2	1 + 2	14.5	198
1	1 + 2	1 + 2	1 + 2	1	1 + 2	15.5	165
21	1 + 2	1 + 2	1 + 2	1	1 + 2	44.4	1,038
7	1 + 2	2	2	2	2	34	532
8	1 + 2	2	2	2	2	42.9	645
12	1 + 2	2	2	2	2	32.9	688
13	1 + 2	2	2	2	2	40.4	664
14	1 + 2	2	2	2	2	2	12
15	1 + 2	2	2	2	2	46.8	724
17	1 + 2	2	2	2	2	46.7	1,062
22	1 + 2	2	2	2	2	42.4	1,213
24	1 + 2	2	2	2	2	28.1	451
25	1 + 2	2	2	2	2	35.5	457
27	1 + 2	2	2	2	2	48.3	1,056
28	1 + 2	2	2	2	2	20.2	504
31	1 + 2	2	2	2	2	39.9	555
35	1 + 2	2	2	2	2	23.6	338
9	1 + 2	1	1	1	1	24.5	270
23	1 + 2	1	1	1	1	22.7	392
18	1 + 2	2	1 + 2	2	2	31.7	514
20	1 + 2	2	1 + 2	2	2	33	416
3	1 + 2	1 + 2	1 + 2	2	2	37.5	574
30	1 + 2	1 + 2	1	1	1	23.3	326
5	1 + 2	1 + 2	1 + 2	1	1	19.8	330
2	1 + 2	1 + 2	1 + 2	1 + 2	1	26.5	445
4	1 + 2	1 + 2	1 + 2	1 + 2	1	3.9	22
6	1 + 2	2	2	2	Both negative	33.1	543
29	1 + 2	2	2	2	Both negative	30	693
32	1 + 2	2	2	2	Both negative	39	936

^a1, HIV-1; 2, HIV-2.